Clinical Trials Logo

Clinical Trial Summary

In this study, blood culture contamination rates will be compared in patients who used povidine/iodine-alcohol and chlorhexidine/alcohol, which were applied before the blood culture was taken by randomized two methods routinely used in this study.


Clinical Trial Description

Detection of the pathogen in blood cultures as soon as possible reduces mortality significantly by providing timely initiation of treatment1. However, when skin antisepsis is not performed properly, an increase in the rate of contamination is observed. In this study, it was planned to compare the contamination rate of two antiseptics, povidine iodine/alcohol and Chlorhexidine/alcohol used as skin antisepsis, in the blood culture taken. Full randomization" will be applied in the study. Multiples of 3 of the patients to be included in the study will be included in the "Chloraprep" group, the remaining patients and multiples of 2 will be included in the "povidine/iodine" group. . According to the number of samples determined for each institution, patients who came to the outpatient clinic during data collection and accepted to participate in the study will be randomly selected. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05576233
Study type Interventional
Source Dr. Behcet Uz Children's Hospital
Contact
Status Not yet recruiting
Phase N/A
Start date October 15, 2023
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT03966534 - Blood Test Order and Culture Contamination N/A
Completed NCT04573894 - Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations